Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GSK plc
  6. News
  7. All News
    GSK   GB00BN7SWP63

GSK PLC

(GSK)
  Report
Delayed London Stock Exchange  -  11:35 2022-11-25 am EST
1392.40 GBX   +0.90%
11/25GSK Canada Submits Respiratory Syncytial Virus Vaccine Candidate For Regulatory Review
RE
11/25Gsk canada submits respiratory syncytial virus (rsv) vaccine can…
RE
11/25FTSE 100 flat as housing, retail stocks weigh
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about GSK PLC
11/25GSK Canada Submits Respiratory Syncytial Virus Vaccine Candidate For Regulatory Review
RE
11/25Gsk canada submits respiratory syncytial virus (rsv) vaccine can…
RE
11/25FTSE 100 flat as housing, retail stocks weigh
RE
11/24Researchers test mRNA technology for universal flu vaccine
RE
11/24Analyst recommendations: Apple, Dollar Tree, GSK...
MS
11/24GSK : Berenberg reiterates its Buy rating
MD
11/23GSK provides an update on Blenrep US marketing authorisation
AQ
11/23GSK provides an update on Blenrep (belantamab mafodotin-blmf) US marketing authorisatio..
AQ
11/22MarketScreener’s World Press Review : November 22, 2..
MS
11/22GSK to Withdraw US Marketing Authorization for Cancer Drug After FDA Request
MT
11/22GSK to Pull Out Multiple Myeloma Drug from US Market Following Disappointing Late-stage..
MT
11/22CORRECT: LONDON MARKET OPEN: Oil stocks lift FTSE amid China concerns
AN
11/22LONDON MARKET OPEN: Oil stocks lift FTSE 100; China concerns persist
AN
11/22FTSE 100 hits two-month high as oil stocks rebound
RE
11/22TOP NEWS: GSK suffers setback as FDA demands withdrawal of cancer drug
AN
11/22LONDON BRIEFING: FTSE 100 called higher as oil prices firm overnight
AN
11/22GSK To Withdraw Blenrep's US Marketing Authorization After FDA Request
DJ
11/22GSK Seeks Cancelation Of US FDA Nod For Blood Cancer Drug After Phase 3 Study Failure
MT
11/22GSK to stop selling blood cancer drug Blenrep in United States
RE
11/22GSK Withdraws U.S. Marketing Authorisation For Blood Cancer Drug Blenrep
RE
11/22GSK to withdraw blood cancer drug from U.S. after trial failure
RE
11/21Rising COVID Cases in China, Plunging Oil Prices Drag European Equities Lower in Monday..
MT
11/21FTSE 100 eases as China COVID surge knocks energy, mining stocks
RE
11/18Vaccines and drugs in the pipeline for RSV
RE
11/17U.S. FDA greenlights Provention Bio's diabetes drug
RE
11/17U.S. FDA greenlights Provention Bio's diabetes drug
RE
11/17Britain's Mitie offers workers winter support package
RE
11/17GSK PLC : Ex-dividend day for interim dividend
FA
11/16CureVac to Deliver Phase 1 Results for Influenza, COVID-19 in Q1 2023
MT
11/16European Equities Flat in Choppy Trade Wednesday as Geopolitical Tensions Weigh
MT
11/16UK dividends calendar - next 7 days
AN
11/15UK Drug Pricing Agency Rejects Merck & Co.'s Molnupiravir, Four Other COVID-19 Treatmen..
MT
11/15Britain's NICE recommends against NHS use of 5 COVID treatments as not cost-effective
RE
11/15European Markets Move Higher Helped by Upbeat US Inflation Data
MT
11/15UK dividends calendar - next 7 days
AN
11/15Gsk : tops Access to Medicine Index (ATMI) for eighth consecutive time
PU
11/15Big pharma not doing enough to improve drug access - analysis
RE
11/15Gsk : BLOCK LISTING SIX MONTHLY RETURN - Form 6-K
PU
11/15LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperfor..
AN
11/15GSK Expects to Accept $2 Billion from Tender Offer for Guaranteed Notes
MT
11/14GSK plc Announces Positive Phase IIa Study Results for A New First-In-Class Candidate M..
CI
11/14European ADRs Continue to Trend Higher in Monday Trading
MT
11/14UK dividends calendar - next 7 days
AN
11/14GSK Says Investigational Agent Was Well Tolerated Among Pulmonary Tuberculosis Patients..
MT
11/14Gsk : announces positive Phase IIa study results for a new first-in-class candidate medici..
PU
11/14GSK Announces Positive Phase IIa Study Results For New First-In-Class Candidate Medicin..
RE
11/14Gsk: gsk3036656 showed early bactericidal activity with low, onc…
RE
11/14Gsk - treatment was generally well tolerated with no serious adv…
RE
11/14Gsk: announces positive phase iia study results for a new first-…
RE
11/14GSK provides an update on Zejula (niraparib) US prescribing information
AQ
11/11Health Care Down Sharply on Rotation -- Health Care Roundup
DJ
11/11Most European Bourses Finish in the Green, But UK FTSE 100 Falls Amid Recession Worries
MT
11/11Correction: US FDA Restricts Second-line Use Of GSK's Zejula In Ovarian Cance..
MT
11/11European ADRs Move Slightly Lower in Friday Trading
MT
11/11UK dividends calendar - next 7 days
AN
11/11GSK to Limit Ovarian Cancer Treatment Zejula's Second-Line Maintenance Indication in US
MT
11/11There's a party in the USA
MS
11/11GSK : Downgraded to Sell by UBS
MD
11/11GSK to restrict US use of cancer drug Zejula to some populations
AN
11/11UBS Downgrades GSK to Sell from Neutral, Cuts PT
MT
11/11Analyst recommendations: Intel, Roku, GSK...
MS
11/11LONDON BROKER RATINGS: UBS cuts Smurfit and GSK; Jefferies likes M..
AN
11/11GSK Will Limit Use of Zejula in the US
DJ
11/11US FDA Restricts Second-line Use Of GSK's Zejula In Ovarian Cancer With BRCA Mutations
MT
11/11GSK to limit U.S. use of ovarian cancer drug to some populations
RE
11/11GSK plc Provides Update on Zejula 2L in US
CI
11/10European Commission Approves Sanofi and GSK's Next-Generation Covid-19 Booster Vaccine ..
CI
11/10GSK Says Sanofi-GSK COVID Booster Vaccine Approved By EU
RE
11/10LONDON MARKET CLOSE: Cooling US inflation triggers risk-on rally
AN
11/10Sanofi, GSK's COVID-19 Booster Shot Gets Regulatory Nod in Europe
MT
11/10UK dividends calendar - next 7 days
AN
11/10Sanofi-GSK COVID-19 Jab Gets EU Commission Approval as Booster
MT
11/10TOP NEWS: Haleon upgrades yearly revenue growth forecast
AN
11/10LONDON MARKET OPEN: Centrica helps FTSE 100 outperform ahead of US CP..
AN
11/10Haleon Upgrades 2022 Views After 3Q Revenue Rose on Pricing, Volumes
DJ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on GSK PLC